This is a snippet of the transcript, sign up to read more.
What I can say is that there has been a feeling in the vet sector that the CMA has been increasingly likely to start an investigation like this over the last five years. The internal view is that this is really about ensuring transparency and consumer choice so that consumers can make effective decisions based on transparent information. It's not necessarily about thinking that costs are too high, but about ensuring consumers can easily access information to make conscious decisions. It's not only about pricing but also about making consumers aware of the difference between a truly independent vet practice and one that might appear independent but is actually corporately owned. That's where I think they're coming from.
This is a snippet of the transcript, sign up to read more.
It's a great challenge, but just from a legal point of view, in terms of transparency, there's a problem there. Whether or not it ultimately affects your decision as a consumer, you are right. But legally, I think people might be falling foul using language such as clinical freedom, family-owned practice, independent, when behind it all sits a corporate.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.